Sign in

CIK 0001374690

  • Non-accelerated filer
  • Smaller reporting company

Larimar Therapeutics, Inc.

Sign in to watch
Ticker
LRMR
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
203857670
Phone
+1 844-511-9056
Business address
THREE BALA PLAZA EAST. SUITE 506, BALA CYNWYD, PA, 19004
Former names
ZAFGEN, INC., ZAFGEN INC
Open-market buys, last 90 days
$392,144
in 8 filings
Open-market sales, last 90 days
$0
in 0 filings

Net +$392,144. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 30 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2019-06-26 LAMATTINA JOHN L Director Grant or award · Stock Option (Right to Buy) +27,000 27,000
2019-01-24 LAMATTINA JOHN L Director Grant or award +10,844 $4.38 $47K 31,376
2018-06-06 LAMATTINA JOHN L Director Grant or award · Stock Option (Right to Buy) +20,000 20,000
2018-01-03 LAMATTINA JOHN L Director Grant or award +9,169 $5.18 $47K 20,532
2017-06-21 LAMATTINA JOHN L Director Grant or award · Stock Option (Right to Buy) +14,500 14,500
2017-02-13 LAMATTINA JOHN L Director Grant or award +11,363 $4.18 $47K 11,363
2016-06-30 LAMATTINA JOHN L Director Grant or award · Stock Option (Right to Buy) +12,000 12,000
2016-01-25 LAMATTINA JOHN L Director Grant or award · Stock Option (Right to Buy) +9,150 9,150

Page 1 of 1 · 8 trades